“…Interestingly, in a series of pregnant women with congenital erythrocytosis (including those with EPAS1 , EGLN1 and EPO mutations) we previously found a possible benefit of aspirin or heparin associated with phlebotomy in the management of these high-risk pregnancies, thus strengthening the appeal of this therapeutic approach in pregnant patients with congenital erythrocytosis. 9 …”